Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
Adicet Bio Inc (NASDAQ: ACET) closed the day trading at $1.88 down -10.71% from the previous closing price of $2.10. In other words, the price has decreased by -$10.71 from its previous closing price. On the day, 1.35 million shares were traded. ACET stock price reached its highest trading level at $2.08 during the session, while it also had its lowest trading level at $1.87.
Ratios:
For a better understanding of ACET, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.41 and its Current Ratio is at 8.41. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.10.
JP Morgan Downgraded its Overweight to Neutral on June 01, 2023, whereas the target price for the stock was revised from $20 to $6.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 25 ’24 when ORBIMED ADVISORS LLC bought 3,125,000 shares for $2.40 per share. The transaction valued at 7,500,000 led to the insider holds 7,526,359 shares of the business.
GORDON CARL L bought 3,125,000 shares of ACET for $7,500,000 on Jan 25 ’24. The Director now owns 7,526,359 shares after completing the transaction at $2.40 per share. On Oct 02 ’23, another insider, Schor Chen, who serves as the President & CEO of the company, bought 5,500 shares for $1.33 each. As a result, the insider paid 7,340 and bolstered with 43,469 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ACET now has a Market Capitalization of 172523424 and an Enterprise Value of 15251720.
Stock Price History:
The Beta on a monthly basis for ACET is 1.87, which has changed by -0.67560554 over the last 52 weeks, in comparison to a change of 0.22640884 over the same period for the S&P500. Over the past 52 weeks, ACET has reached a high of $7.50, while it has fallen to a 52-week low of $1.10. The 50-Day Moving Average of the stock is -19.79%, while the 200-Day Moving Average is calculated to be -8.01%.
Shares Statistics:
Over the past 3-months, ACET traded about 1.39M shares per day on average, while over the past 10 days, ACET traded about 731000 shares per day. A total of 82.17M shares are outstanding, with a floating share count of 67.18M. Insiders hold about 18.24% of the company’s shares, while institutions hold 43.10% stake in the company. Shares short for ACET as of 1711584000 were 7687094 with a Short Ratio of 5.54, compared to 1709164800 on 5657556. Therefore, it implies a Short% of Shares Outstanding of 7687094 and a Short% of Float of 10.84.
Earnings Estimates
At present, 5.0 analysts are actively evaluating the performance of Adicet Bio Inc (ACET) in the stock market.On average, analysts expect EPS of -$0.39 for the current quarter, with a high estimate of -$0.27 and a low estimate of -$0.51, while EPS last year was -$0.72. The consensus estimate for the next quarter is -$0.35, with high estimates of -$0.27 and low estimates of -$0.39.
Analysts are recommending an EPS of between -$1.09 and -$3.05 for the fiscal current year, implying an average EPS of -$1.86. EPS for the following year is -$1.88, with 7.0 analysts recommending between -$1.05 and -$3.41.
